Latest News & Features
AI
Guidance says use of AI in inventing does not affect how patent claims are assessed for eligibility | Emphasis placed on evaluating inventions themselves rather than the method of creation | Updates include new examples to assist examiners in evaluating AI-related patent claims. 17 July 2024
Careers
Highly experienced addition spent 24 years at Clifford Chance | Brings experience handling transactions across many sectors, including financial services and telecoms | Addition is set to drive the expansion of Kirkland's London practice. 16 July 2024
Standard essential patents
Counsel for the automaker faced criticism for “perfunctory and inadequate” submissions | Tesla needs worldwide licence for all its 5G SEPs but objects to Avanci’s terms | Bid failed on jurisdictional grounds. 16 July 2024
Trade secrets
US efforts must form part of a global campaign to protect rights and combat threats to the world’s largest innovation economy, says Frank Cullen, executive director of the Council for Innovation Promotion. 16 July 2024
Standard essential patents
Chipmaker says it wants to restore a “level playing field” for licensees | China-based mobile phone giant argues such suits don't factor in economic differences between regions. 15 July 2024
Patents
Chipmaker asked Delaware court for declaratory judgment on patent licence | Intel said lawsuit was ninth attempt to litigate patent rights with NPE. 15 July 2024
Standard essential patents
Lord Justice Arnold questions Judge Mellor’s ‘inconsistent’ previous ruling in Levovo dispute but largely aligns | Lord Justice Birss ‘surprised it took so long to produce draft judgment’ | InterDigital’s bid for 49-50 US cents per unit cut to 22.5 US cents. 12 July 2024
Copyright
Hip-hop group claims restaurant chain’s 1970’s-style commercial evokes 30-year-old music video | Beastie Boys refuse licences for third-party product advertising purposes in deference to late band member Adam Yauch’s wishes. 12 July 2024
Careers
Firm adds automotive expert with extensive trial and appellate experience | New chair of Hatch-Waxman & Biologics Practice is an FDA and pharma litigation expert who will ‘provide clarity in an uncertain post-Chevron world’. 12 July 2024
Artificial Intelligence
The Bundesgerichtshof's DABUS decision offers a path for European harmonisation—with the US playing catchup, explains DABUS patent attorney Malte Köllner of Köllner & Partner. 12 July 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.